annual D&A:
$6.07B-$2.21B(-26.68%)Summary
- As of today (May 20, 2025), NVS annual depreciation & amortization is $6.07 billion, with the most recent change of -$2.21 billion (-26.68%) on December 31, 2024.
- During the last 3 years, NVS annual D&A has risen by +$472.00 million (+8.43%).
- NVS annual D&A is now -26.68% below its all-time high of $8.28 billion, reached on December 31, 2023.
Performance
NVS Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.15B-$474.00M(-29.12%)Summary
- As of today (May 20, 2025), NVS quarterly depreciation & amortization is $1.15 billion, with the most recent change of -$474.00 million (-29.12%) on March 31, 2025.
- Over the past year, NVS quarterly D&A has dropped by -$160.00 million (-12.18%).
- NVS quarterly D&A is now -74.54% below its all-time high of $4.53 billion, reached on September 30, 2017.
Performance
NVS quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$5.91B-$160.00M(-2.64%)Summary
- As of today (May 20, 2025), NVS TTM depreciation & amortization is $5.91 billion, with the most recent change of -$160.00 million (-2.64%) on March 31, 2025.
- Over the past year, NVS TTM D&A has dropped by -$1.81 billion (-23.47%).
- NVS TTM D&A is now -30.57% below its all-time high of $8.51 billion, reached on September 30, 2023.
Performance
NVS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NVS Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.7% | -12.2% | -23.5% |
| 3 y3 years | +8.4% | -17.9% | +11.4% |
| 5 y5 years | +4.2% | -18.2% | +2.0% |
NVS Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -26.7% | +8.4% | -62.9% | at low | -30.6% | +11.4% |
| 5 y | 5-year | -26.7% | +8.4% | -62.9% | +15.1% | -30.6% | +11.4% |
| alltime | all time | -26.7% | +719.0% | -74.5% | +282.0% | -30.6% | +1843.8% |
NVS Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.15B(-29.1%) | $5.91B(-2.6%) |
| Dec 2024 | $6.07B(-26.7%) | $1.63B(-17.2%) | $6.07B(+0.7%) |
| Sep 2024 | - | $1.97B(+69.1%) | $6.03B(-16.0%) |
| Jun 2024 | - | $1.16B(-11.6%) | $7.17B(-7.1%) |
| Mar 2024 | - | $1.31B(-17.3%) | $7.72B(-6.7%) |
| Dec 2023 | $8.28B(+23.4%) | $1.59B(-49.0%) | $8.28B(-2.7%) |
| Sep 2023 | - | $3.11B(+82.1%) | $8.51B(+20.3%) |
| Jun 2023 | - | $1.71B(-8.7%) | $7.08B(-1.3%) |
| Mar 2023 | - | $1.87B(+2.6%) | $7.17B(+6.9%) |
| Dec 2022 | $6.71B(+19.8%) | $1.82B(+8.7%) | $6.71B(+13.9%) |
| Sep 2022 | - | $1.68B(-7.0%) | $5.89B(+3.9%) |
| Jun 2022 | - | $1.80B(+28.3%) | $5.66B(+6.7%) |
| Mar 2022 | - | $1.41B(+40.1%) | $5.30B(-5.2%) |
| Dec 2021 | $5.60B(-13.4%) | $1.00B(-31.0%) | $5.60B(-9.9%) |
| Sep 2021 | - | $1.45B(+0.6%) | $6.21B(-4.3%) |
| Jun 2021 | - | $1.44B(-14.9%) | $6.49B(-3.8%) |
| Mar 2021 | - | $1.70B(+4.9%) | $6.75B(+4.4%) |
| Dec 2020 | $6.46B(+11.0%) | $1.62B(-6.7%) | $6.46B(-4.7%) |
| Sep 2020 | - | $1.73B(+1.8%) | $6.78B(+5.1%) |
| Jun 2020 | - | $1.70B(+20.8%) | $6.45B(+11.3%) |
| Mar 2020 | - | $1.41B(-27.2%) | $5.79B(-0.5%) |
| Dec 2019 | $5.83B(+11.8%) | $1.94B(+38.2%) | $5.83B(+5.4%) |
| Sep 2019 | - | $1.40B(+34.0%) | $5.53B(+0.7%) |
| Jun 2019 | - | $1.05B(-27.4%) | $5.49B(-2.8%) |
| Mar 2019 | - | $1.44B(-11.9%) | $5.65B(+8.4%) |
| Dec 2018 | $5.21B(+10.0%) | $1.64B(+19.9%) | $5.21B(+37.9%) |
| Sep 2018 | - | $1.36B(+13.3%) | $3.78B(-45.6%) |
| Jun 2018 | - | $1.21B(+19.9%) | $6.95B(+21.0%) |
| Mar 2018 | - | $1.00B(+395.1%) | $5.74B(+21.2%) |
| Dec 2017 | $4.74B(-21.6%) | $203.00M(-95.5%) | $4.74B(-24.0%) |
| Sep 2017 | - | $4.53B(+166.6%) | $6.23B(+3.1%) |
| Dec 2016 | $6.04B(+10.5%) | $1.70B(+12.7%) | $6.04B(+6.6%) |
| Sep 2016 | - | $1.51B(+2.9%) | $5.67B(+2.8%) |
| Jun 2016 | - | $1.47B(+7.1%) | $5.51B(-0.8%) |
| Mar 2016 | - | $1.37B(+3.3%) | $5.56B(+1.6%) |
| Dec 2015 | $5.47B(+16.9%) | $1.32B(-2.2%) | $5.47B(+1.9%) |
| Sep 2015 | - | $1.35B(-10.2%) | $5.37B(+3.6%) |
| Jun 2015 | - | $1.51B(+17.7%) | $5.18B(+6.9%) |
| Mar 2015 | - | $1.28B(+4.9%) | $4.85B(+3.5%) |
| Dec 2014 | $4.68B | $1.22B(+4.7%) | $4.68B(+1.5%) |
| Sep 2014 | - | $1.17B(-0.7%) | $4.61B(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $1.18B(+5.1%) | $4.54B(+5.0%) |
| Mar 2014 | - | $1.12B(-3.1%) | $4.33B(-1.7%) |
| Dec 2013 | $4.41B(-0.8%) | $1.15B(+5.2%) | $4.41B(+6.8%) |
| Sep 2013 | - | $1.10B(+14.3%) | $4.12B(-3.2%) |
| Jun 2013 | - | $960.00M(-19.6%) | $4.26B(-5.2%) |
| Mar 2013 | - | $1.19B(+36.9%) | $4.49B(+1.1%) |
| Dec 2012 | $4.44B(-23.3%) | $872.00M(-29.2%) | $4.44B(+24.4%) |
| Sep 2012 | - | $1.23B(+3.2%) | $3.57B(+52.7%) |
| Jun 2012 | - | $1.19B(+4.4%) | $2.34B(+104.4%) |
| Mar 2012 | - | $1.14B(-57.2%) | $1.14B(-57.2%) |
| Dec 2011 | $5.79B(+69.3%) | - | - |
| Dec 2010 | $3.42B(+48.6%) | - | - |
| Dec 2009 | $2.30B(-13.8%) | - | - |
| Dec 2008 | $2.67B(-6.6%) | $2.67B(-521.1%) | $2.67B(+53.6%) |
| Jun 2008 | - | -$634.00M(-200.0%) | $1.74B(-41.1%) |
| Mar 2008 | - | $634.00M(-19.2%) | $2.95B(+3.3%) |
| Dec 2007 | $2.86B(+48.6%) | $785.00M(-17.6%) | $2.86B(+10.1%) |
| Sep 2007 | - | $953.00M(+64.3%) | $2.60B(+17.7%) |
| Jun 2007 | - | $580.00M(+7.4%) | $2.21B(+8.5%) |
| Mar 2007 | - | $540.00M(+3.1%) | $2.04B(+5.8%) |
| Dec 2006 | $1.92B(+18.6%) | $524.00M(-6.9%) | $1.92B(-1.0%) |
| Sep 2006 | - | $563.00M(+38.0%) | $1.94B(+3.5%) |
| Jun 2006 | - | $408.00M(-4.7%) | $1.88B(+6.5%) |
| Mar 2006 | - | $428.00M(-21.3%) | $1.76B(+8.8%) |
| Dec 2005 | $1.62B(+24.8%) | $544.00M(+9.2%) | $1.62B(+14.1%) |
| Sep 2005 | - | $498.00M(+69.4%) | $1.42B(+13.4%) |
| Jun 2005 | - | $294.00M(+3.2%) | $1.25B(-1.7%) |
| Mar 2005 | - | $285.00M(-17.2%) | $1.27B(-1.8%) |
| Dec 2004 | $1.30B(+1.2%) | $344.00M(+4.2%) | $1.30B(+1.2%) |
| Sep 2004 | - | $330.00M(+4.4%) | $1.28B(-2.4%) |
| Jun 2004 | - | $316.00M(+2.3%) | $1.31B(+2.1%) |
| Mar 2004 | - | $309.00M(-6.1%) | $1.29B(+0.4%) |
| Dec 2003 | $1.28B(-0.9%) | $329.00M(-8.9%) | $1.28B(+34.5%) |
| Sep 2003 | - | $361.00M(+24.9%) | $954.00M(+60.9%) |
| Jun 2003 | - | $289.00M(-4.9%) | $593.00M(+95.1%) |
| Mar 2003 | - | $304.00M | $304.00M |
| Dec 2002 | $1.29B(+24.9%) | - | - |
| Dec 2001 | $1.04B(+39.9%) | - | - |
| Dec 2000 | $741.00M(-21.8%) | - | - |
| Dec 1999 | $948.00M(-6.0%) | - | - |
| Dec 1998 | $1.01B | - | - |
FAQ
- What is Novartis AG annual depreciation & amortization?
- What is the all time high annual D&A for Novartis AG?
- What is Novartis AG annual D&A year-on-year change?
- What is Novartis AG quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Novartis AG?
- What is Novartis AG quarterly D&A year-on-year change?
- What is Novartis AG TTM depreciation & amortization?
- What is the all time high TTM D&A for Novartis AG?
- What is Novartis AG TTM D&A year-on-year change?
What is Novartis AG annual depreciation & amortization?
The current annual D&A of NVS is $6.07B
What is the all time high annual D&A for Novartis AG?
Novartis AG all-time high annual depreciation & amortization is $8.28B
What is Novartis AG annual D&A year-on-year change?
Over the past year, NVS annual depreciation & amortization has changed by -$2.21B (-26.68%)
What is Novartis AG quarterly depreciation & amortization?
The current quarterly D&A of NVS is $1.15B
What is the all time high quarterly D&A for Novartis AG?
Novartis AG all-time high quarterly depreciation & amortization is $4.53B
What is Novartis AG quarterly D&A year-on-year change?
Over the past year, NVS quarterly depreciation & amortization has changed by -$160.00M (-12.18%)
What is Novartis AG TTM depreciation & amortization?
The current TTM D&A of NVS is $5.91B
What is the all time high TTM D&A for Novartis AG?
Novartis AG all-time high TTM depreciation & amortization is $8.51B
What is Novartis AG TTM D&A year-on-year change?
Over the past year, NVS TTM depreciation & amortization has changed by -$1.81B (-23.47%)